Raymond James Trust N.A. Repligen Corp Transaction History
Raymond James Trust N.A.
- $4.22 Billion
- Q2 2024
A detailed history of Raymond James Trust N.A. transactions in Repligen Corp stock. As of the latest transaction made, Raymond James Trust N.A. holds 2,275 shares of RGEN stock, worth $320,092. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,275
Previous 2,320
1.94%
Holding current value
$320,092
Previous $426,000
32.86%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding RGEN
# of Institutions
497Shares Held
54MCall Options Held
423KPut Options Held
85.3K-
Black Rock Inc. New York, NY7.57MShares$1.06 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.07MShares$713 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.61MShares$648 Million0.07% of portfolio
-
State Street Corp Boston, MA1.74MShares$244 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.42MShares$200 Million0.55% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.81B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....